Impact of diabetes, chronic heart failure, congenital heart disease and chronic obstructive pulmonary disease on acute and chronic exercise responses

Canadian Journal of Cardiology

Volumn 23, Issue SUPPL. B, 2007, Pages 89B-96B

  Brassard, Patrice ^a   Ferland, Annie ^a   Marquis, Karine ^a   Maltais, François ^a   Jobin, Jean ^a   Poirier, Paul ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Chronic heart failure; Chronic obstructive pulmonary disease; Congenital heart disease; Exercise response; Exercise training; Type 2 diabetes mellitus

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDIABETIC AGENT; CARNITINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; LONG CHAIN FATTY ACID; OXYGEN;

AEROBIC CAPACITY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGENITAL HEART DISEASE; ENERGY METABOLISM; ENERGY RESOURCE; EXERCISE; EXERCISE TOLERANCE; FATTY ACID TRANSPORT; GLYCEMIC CONTROL; HEART FAILURE; HEART REHABILITATION; HUMAN; LIPOLYSIS; MEDICAL RESEARCH; MUSCLE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; OXYGEN TRANSPORT; PATIENT CARE; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; PULMONARY REHABILITATION; PULMONOLOGY; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE;

EID: 35448993337     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0828-282x(07)71018-8     Document Type: Article

References (110)

1. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/ exercise and type 2 diabetes. Diabetes Care 2004;27:2518-39.
2. Kang J, Kelley DE, Robertson RJ, et al. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 1999;31:82-9.
3. Poirier P, Mawhinney S, Grondin L, et al. Prior meal enhances the plasma glucose lowering effect of exercise in type 2 diabetes. Med Sci Sports Exerc 2001;33:1259-64.
4. Minuk HL, Vranic M, Marliss EB, et al. Glucoregulatory and metabolic response to exercise in obese noninsulin-dependent diabetes. Am J Physiol 1981;240:E458-64.
5. Larsen JJ, Dela F, Kjaer M, Galbo H. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 1997;40:447-53.
6. Gaudet-Savard T, Ferland A, Broderick TL, et al. Safety and magnitude of changes of blood glucose levels following exercise performed in the fasted and and the postprandial state in type 2 diabetes men. Eur J Cardiovasc Prev Rehabil 2007. (In press)
7. Duh E, Feinglos M. Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med 1994;121:945-6.
8. Zinman B, Murray FT, Vranic M, et al. Glucoregulation during moderate exercise in insulin-treated diabetes. J Clin Endocrinol Metab 1977;45:641-52.
9. Bremer J. Carnitine - metabolism and functions. Physiol Rev 1983;63:1420-80.
10. Lennon DL, Stratman FW, Shrago E, et al. Effects of acute moderateintensity exercise on carnitine metabolism in men and women. J Appl Physiol 1983;55:489-95.
11. Carlin JI, Reddan WG, Sanjak M, Hodach R. Carnitine metabolism during prolonged exercise and recovery in humans. J Appl Physiol 1986;61:1275-8.
12. Ferland A, Broderick TL, Nadeau A, Simard S, Martin J, Poirier P. Impact of fasting and postprandial state on plasma carnitine concentrations during aerobic exercise in type 2 diabetes. Acta Diabetol 2007;44:114-20.
13. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine position stand. Exercise and type 2 diabetes. Med Sci Sports Exerc 2000;32:1345-60.
14. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006;29(Suppl 1):S4-42.
15. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002;25:148-98.
16. Wolever TMS, Gougeon R, Freeze C, et al. Nutrition therapy. Can J Diabetes Care 2003;15:S27-S31.
17. Gougeon R, Spidel M, Lee K, Field CJ. Canadian Diabetes Association National Nutrition Committee Technical Review: Non-nutritive intense sweeteners in diabetes management. Can J Diabetes 2004;28:385-99.
18. Ferland A, Brassard P, Poirier P. Is aspartame really safer on risk to induce hypoglycemia during exercise in type 2 diabetic patients? Diabetes Care 2007;30:e59.
19. Ferland A, Turbide G, Bogaty P, Jobin J, Larivière MM, Poirier P. Type 2 diabetes and aerobic exercise - Is prior breakfast deleterious? Med Sci Sports Exerc 2004;36(5 Suppl):S216.
20. Turgan N, Coker C, Hamulu F, et al. Glucose metabolism and catecholamine responses during physical exercise in non-insulin-dependent diabetes. Eur J Clin Chem Clin Biochem 1996;34:683-9.
21. Ferland A, Brassard P, Lemieux S, et al. Impact of aspartame and sucrose on adrenergic response to aerobic exercise in type 2 diabetic patients. Med Sci Sports Exerc 2006;38(Suppl 5):1395.
22. Herlitz J, Malmberg K. How to improve the cardiac prognosis for diabetes. Diabetes Care 1999;22(Suppl 2):B89-B96.
23. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: Blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138:593-602.
24. McKenney JM, Goodman RP, Wright JT Jr. Use of antihypertensive agents in patients with glucose intolerance. Clin Pharm 1985;4:649-56.
25. Veronee CD, Lewis WR, Takla MW, et al. Protective metabolic effects of propranolol during total myocardial ischemia. J Thorac Cardiovasc Surg 1986;92:425-33.
26. Estacio RO, Regensteiner JG, Wolfel EE, et al. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care 1998;21:291-5.
27. Regensteiner JG, Sippel J, McFarling ET, et al. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995;27:875-81.
28. Regensteiner JG, Bauer TA, Reusch JE, et al. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 1998;85:310-7.
29. Roy TM, Peterson HR, Snider HL, et al. Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med 1989;87:382-8.
30. 2 difference in type 2 diabetes. J Appl Physiol 2003; 94:1033-8.
31. Brassard P, Ferland A, Croteau S, et al. Impact of beta-blockade on exercise capacity in subjects with type 2 diabetes. Clin Invest Med 2007;In press.
32. Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: Importance of maneuvers in echocardiogtaphic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10.
33. Poirier P, Garneau C, Bogaty P, et al. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 2000;85:473-7.
34. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: The Strong Heart Study. Circulation 2000; 101:2271-6.
35. Chen CH, Nakayama M, Nevo E, et al. Coupled systolic-ventricular and vascular stiffening with age: Implications for pressure regulation and cardiac reserve in the elderly. J Am Cull Cardiol 1998;32:1221-7.
36. Kokkinos PF, Andreas PE, Coutoulakis E, et al. Determinants of exercise blood pressure response in normotensive and hypertensive women: Role of cardiorespiratory fitness. J Cardiopulm Rehabil 2002;22:178-83.
37. Karjalainen J, Mantysaari M, Viitasalo M, Kujala U. Left ventricular mass, geometry, and filling in endurance athletes: Association with exercise blood pressure. J Appl Physiol 1997;82:531-7.
38. Brassard P, Ferland A, Gaudreault V, et al. Elevated peak exercise systolic blood pressure is not associated with reduced exercise capacity in subjects with type 2 diabetes. J Appl Physiol 2006;101:893-7.
39. Dwyer GB, Wallace JP, Whaley MH. Influence of metabolic control on the ventilatory threshold in adults with non insulin-dependent diabetes mellitus. Diabetes Res 1994;25:39-46.
40. Demir I, Ermis C, Altunbas H, Balci MK. Serum HbAlc levels and exercise capacity in diabetic patients. Jpn Heart J 2001;42:607-16.
41. Vanninen E, Uusitupa M, Remes J, et al. Relationship between hyperglycaemia and aerobic power in men with newly diagnosed type 2 (non insulin-dependent) diabetes. Clin Physiol 1992;12:667-77.
42. Fang ZY, Sharman J, Prins JB, Marwick TH. Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care 2005;28:1643-8.
43. Davis WA, Knuiman M, Kendall P, et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care 2004;27:752-7.
44. Ditzel J. Oxygen transport impairment in diabetes. Diabetes 1976;25:832-8.
45. Kingwell BA, Formosa M, Muhlmann M, et al. Type 2 diabetic individuals have impaired leg blood flow responses to exercise: Role of endothelium-dependent vasodilation. Diabetes Care 2003;26:899-904.
46. Ditzel J. Changes in red cell oxygen release capacity in diabetes mellitus. Fed Proc 1979;38:2484-8.
47. Ditzel J, Standl E. The problem of tissue oxygenation in diabetes mellitus. I. Its relation to the early functional changes in the microcirculation of diabetic subjects. Acta Med Scand Suppl 1975;578:49-58.
48. Ditzel J, Standl E. The problem of tissue oxygenation in diabetes mellitus. Acta Med Scand Suppl 1975;578:59-68.
49. Brassard P, Ferland A, Bogaty P, et al. Influence of glycemic control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus. Metabolism 2006;55:1532-7.
50. Higginbotham MB, Morris KG, Conn EH, et al. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983;51:52-60.
51. Franciosa JA, Ziesche S, Wilen M. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Am J Med 1979;67:460-6.
52. Szlachcic J, Massie BM, Kramer BL, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55:1037-42.
53. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
54. Jobin J, Doyon JF. Peripheral muscle limitations to exercise in patients with congestive heart failure: Implications for rehabilitation. In: Jobin J, Maltais F, LeBlanc P, Simard C, eds. Advances in Cardiopulmonary Rehabilitation. Champaign: Human Kinetics, 2000:90-104.
55. Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758-64.
56. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
57. Drexler H, Riede U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
58. Maltais F, Débigaré R, Saey D, Jobin J. Peripheral muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Two diseases, one common consequence. In: Jobin J, Maltais F, Poirier P, LeBlanc P, Simard C, eds. Advancing the Frontiers of Cardiopulmonary Rehabilitation. Champaign: Human Kinetics, 2002:181-92.
59. De Luca CJ. Myoelectrical manifestations of localized muscular fatigue in humans. Crit Rev Biomed Eng 1984;11:251-79.
60. Buonocore M, Opasich C, Casale R. Early development of EMG localized muscle fatigue in hand muscles of patients with chronic heart failure. Arch Phys Med Rehabil 1998;79:41-5.
61. Brassard P, Maltais F, Noel M, et al. Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure. Can J Cardiol 2006;22:387-92.
62. Brassard P, Bedard E, Jobin J, et al. Exercise capacity and impact of exercise training in patients after a Fontan procedure: A review. Can J Cardiol 2006;22:489-95.
63. Zellers TM, Driscoll DJ, Mottram CD, et al. Exercise tolerance and cardiorespiratory response to exercise before and after the Fontan operation. Mayo Clin Proc 1989;64:1489-97.
64. Driscoll DJ, Danielson GK, Puga FJ, et al. Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol 1986;7:1087-94.
65. Brassard P, Poirier P, Martin J, et al. Impact of exercise training on muscle function and ergoreflex in Fontan patients: A pilot study. Int J Cardiol 2006;107:85-94.
66. Webb G. Improving the care of Canadian adults with congenital heart disease. Can J Cardiol 2005;21:833-8.
67. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-47.
68. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001;2:216-24.
69. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
70. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
71. Bernard S, Leblanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
72. Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-67.
73. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-13.
74. Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: Capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 1998;18:432-7.
75. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-74.
76. Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-93.
77. Payen JF, Wuyam B, Levy P, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993;147:592-8.
78. Maltais F, Jobin J, Sullivan MJ, et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol 1998;84:1573-80.
79. Hultman E, Del Canale S, Sjoholm H. Effect of induced metabolic acidosis on intracellular pH, buffer capacity and contraction force of human skeletal muscle. Clin Sci (Lond) 1985;69:505-10.
80. Maltais F, Bernard S, Jobin J, et al. Lactate kinetics during exercise in chronic obstructive pulmonary disease. Can Respir J 1997;4:251-7.
81. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
82. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
83. Allaire J, Maltais F, Doyon JF, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004;59:673-8.
84. Saey D, Debigare R, Leblanc P, et al. Contractile leg fatigue after cycle exercise: A factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:425-30.
85. Goldstein RS, Gort EH, Stubbing D, et al. Randomised controlled trial of respiratory rehabilitation. Lancet 1994;344:1394-7.
86. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; CD003793.
87. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet 2000;355:362-8.
88. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-32.
89. Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:9-18.
90. Maltais F, Leblanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
91. Puente-Maestu L, Sanz ML, Sanz P, et al. Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. Eur Respir J 2000;15:1026-32.
92. Maltais F, Leblanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:555-61.
93. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
94. Simpson K, Killian K, McCartney N, et al. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992;47:70-5.
95. Spruit MA, Gosselink R, Troosters T, et al. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002;19:1072-8.
96. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
97. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
98. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995;19(Suppl 1):S52-9.
99. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev 1998;20:157-72.
100. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005;25:226-32.
101. Mundal R, Kjeldsen SE, Sandvik L, et al. Exercise blood pressure predicts cardiovascular mortality in middle-aged men. Hypertension 1994;24:56-62.
102. Mundal R, Kjeldsen SE, Sandvik L, et al. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension 1996;27:324-9.
103. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992;20:333-9.
104. Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004;36:533-53.
105. Maltais F, Whittom F, Leblanc P, et al. Blood pressure and double product increases during exercise in patients with COPD. Am J Respir Crit Care Med 1998;157:A451. (Abst)
106. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-72.
107. Lacasse M, Maltais F, Poirier P, et al. Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med 2005;99:877-86.
108. Marquis K, Maltais F, Poirier P. L'exercice est-il suffisant pour diminuer la tension artérielle chez les patients atteints d'une MPOC ? Médecine/Sciences 2006;22:S20.
109. Marquis K, Maltais F, Fortin C, Poirier E Effets de l'entraînement et de l'Irbesartan sur la variabilité cardiaque des patients atteints d'une MPOC. Médecine/Sciences 2006;22:S20.
110. Jobin J, Maltais F, Leblanc P, Simard C. Advances in Cardiopulmonary Rehabilitation, Human Kinetics. Illinois: Human Kinetics, 2000.